COMMUNIQUÉS West-GlobeNewswire

iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States

18/10/2018 - 15:51

NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced [...]

BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

18/10/2018 - 15:45

MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the [...]

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China

18/10/2018 - 15:05

RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today [...]

Making Breast Cancer Surgery Easier for Women: Over 50,000 Women in U.S. Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®

18/10/2018 - 15:00

ALISO VIEJO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that over 375 hospitals across the United States have collectively performed over [...]

RefleXion to Unveil New Approach to Cancer Treatment at ASTRO

18/10/2018 - 15:00

Biology-guided Radiotherapy May Improve Physician Confidence in Treatment of Multiple Tumors HAYWARD, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical , a biotargeting oncology company using each cancer’s [...]

CTV Toronto Highlights FSD Pharma’s Cobourg Facility -- CFN Media

18/10/2018 - 15:00

SEATTLE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Predictive Technology Group Appoints Charles Andres to Its Scientific Advisory Board

18/10/2018 - 15:00

SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]

Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII

18/10/2018 - 14:30

Mepsevii, an enzyme replacement therapy, is the first treatment approved in Latin America for this rare genetic disease NOVATO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]

Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy

18/10/2018 - 14:30

Intellia scientists present first robust demonstration of CRISPR-mediated insertion of transgenes in the liver Non-human primate data show high correlation achieved between liver edit and reduction of TTR protein High [...]

OpGen Announces Pricing of Public Offering of Common Stock

18/10/2018 - 14:14

GAITHERSBURG, Md., Oct. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced the pricing of an underwritten public offering of approximately 2.2 million shares of its common stock at a public offering [...]

Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results

18/10/2018 - 14:05

SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

18/10/2018 - 14:03

NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions

18/10/2018 - 14:02

MIAMI, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced the beta launch of its new proprietary tele-pharmacy software [...]

Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018

18/10/2018 - 14:01

IRVINE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that it will release 2018 third quarter financial results after the close of U.S [...]

swyMed Joins AT&T's FirstNet Dealer Program

18/10/2018 - 14:00

Industry Experts in Public Safety Can Now Market, Promote and Co-Sell FirstNet Services LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- swyMed, a provider of industry leading telemedicine and connectivity solutions [...]

Samumed to Present Preclinical Data on SM07883 at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Congress

18/10/2018 - 14:00

SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present preclinical data on the company’s novel DYRK1A inhibitor, SM07883, a potential first-in-class drug for the treatment of [...]

Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings

18/10/2018 - 14:00

NEWTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]

Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033

18/10/2018 - 14:00

BEDMINSTER, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office (“USPTO”) [...]

Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA

18/10/2018 - 14:00

TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]